Evidence map›Paper›PMID 26468043›Full record

Trial reportEpidemiology and infection2016

Under-recognized pertussis in adults from Asian countries: a cross-sectional seroprevalence study in Malaysia, Taiwan and Thailand.

M T Koh, C-S Liu, C-H Chiu, W Boonsawat, V Watanaveeradej, N Abdullah, Xh Zhang, R Devadiga, J Chen

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Epidemiology and infection, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Immune persistence after pertussis vaccination.Human vaccines & immunotherapeutics · 2017
    Review
  13. Review
  14. [Pertussis diagnosis: the limitation of the currently used criteria and the suggestion of Global Pertussis Initiative].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2016
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

M T KohUniversity of Malaya,Kuala Lumpur,Malaysia.
C-S LiuFamily Medicine Department,China Medical University Hospital,Taichung,Taiwan.
C-H ChiuDivision of Pediatric Infectious Diseases,Department of Pediatrics,Chang Gung Children's Hospital,Chang Gung University,Taoyuan,Taiwan.
W BoonsawatKhon Kaen University,Thailand.
V WatanaveeradejDepartment of Pediatrics,Phramongkutklao Hospital,Bangkok,Thailand.
N AbdullahUniversity of Malaya,Kuala Lumpur,Malaysia.
Xh ZhangGSK Vaccines,Singapore.
R DevadigaGSK Vaccines,Bangalore,India.
J ChenGSK Vaccines,Singapore.
University of Malaya · MYChang Gung Children's Hospital · TWChina Medical University Hospital · TWKhon Kaen University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surveillance data on the burden of pertussis in Asian adults are limited. This cross-sectional study evaluated the prevalence of serologically confirmed pertussis in adults with prolonged cough in Malaysia, Taiwan and Thailand. Adults (⩾19 years) with cough lasting for ⩾14 days without other known underlying cause were enrolled from outpatient clinics of seven public and/or private hospitals. Single blood samples for anti-pertussis toxin antibodies (anti-PT IgG) were analysed and economic impact and health-related quality of life (EQ-5D) questionnaires assessed. Sixteen (5·13%) of the 312 chronically coughing adults had serological evidence of pertussis infection within the previous 12 months (anti-PT IgG titre ⩾62·5 IU/ml). Three of them were teachers. Longer duration of cough, paroxysms (75% seroconfirmed, 48% non-seroconfirmed) and breathlessness/chest pain (63% seroconfirmed, 36% non-seroconfirmed) were associated with pertussis (P < 0·04). Of the seroconfirmed patients, the median total direct medical cost per pertussis episode in public hospitals (including physician consultations and/or emergency room visits) was US$13 in Malaysia, US$83 in Taiwan (n = 1) and US$26 in Thailand. The overall median EQ-5D index score of cases was 0·72 (range 0·42-1·00). Pertussis should be considered in the aetiology of adults with a prolonged or paroxysmal cough, and vaccination programmes considered.

Indexed as

AdultAntibodies, BacterialBordetella pertussisCross-Sectional StudiesFemaleHumansMalaysiaMaleMiddle AgedPertussis ToxinPrevalenceSeroepidemiologic StudiesTaiwanThailandWhooping CoughYoung AdultAntibodies, BacterialPertussis ToxinBordetella pertussisepidemiologyinfectious disease epidemiologypertussis (whooping cough)public health

Identifiers

PMID26468043
PMCPMC4825214
OpenAlexW2139538862

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.